Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06495658
NA

Impact of Prebiotics in Ulcerative Colitis

Sponsor: University of California, Los Angeles

View on ClinicalTrials.gov

Summary

The cause of inflammatory bowel disease (IBD) is currently unknown, although partly attributed to interactions among genetic risk polymorphisms, environmental factors, gut microbiome, and host immunity. Diet, particularly those with plant-based products, have been shown in prior research to improve gut microbial composition, which has been linked to different IBD-related outcomes. This study is interested in evaluating the impact of prebiotics on gut microbiome composition and gut health in patients with IBD. Dietary composition will be assessed at baseline and over the course of 16 weeks. Participants will be randomized to either consume an 8-week course of prebiotic supplementation beginning at week 0 or week 8. Stool samples will be collected at weeks 0 and 8. The stool will be analyzed for cross-sectional and longitudinal fecal microbial changes associated with different prebiotic and diet consumption patterns in the context of heterogeneous disease characteristics.

Official title: The Clinical and Microbial Impact of Prebiotics in Ulcerative Colitis

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

70

Start Date

2024-07-09

Completion Date

2027-12-31

Last Updated

2026-02-27

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Prebiotic

Participants will be asked to take a daily dose of prebiotic supplement for 8 weeks.

Locations (1)

UCLA

Los Angeles, California, United States